(CRS) Carpenter Technology - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US1442851036
Stock: Alloy Steel, Titanium, Powder Metals, Stainless Steel
Total Rating 73
Risk 87
Buy Signal -0.77
| Risk 5d forecast | |
|---|---|
| Volatility | 45.3% |
| Relative Tail Risk | -10.5% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.81 |
| Alpha | 105.30 |
| Character TTM | |
|---|---|
| Beta | 1.568 |
| Beta Downside | 1.501 |
| Drawdowns 3y | |
|---|---|
| Max DD | 28.74% |
| CAGR/Max DD | 3.85 |
EPS (Earnings per Share)
Revenue
Description: CRS Carpenter Technology March 03, 2026
Carpenter Technology Corporation (NYSE: CRS) is a global manufacturer and distributor of specialty metals, headquartered in Philadelphia. Founded in 1889, the company operates through two primary segments: Specialty Alloys Operations and Performance Engineered Products. Its portfolio includes high-performance materials such as titanium alloys, powder metals, and stainless steels designed for mission-critical applications in the aerospace, defense, medical, and energy sectors.
The specialty metals industry is characterized by high barriers to entry due to the technical complexity of vacuum melting and powder atomization processes. Unlike commodity steel producers, Carpenter Technology utilizes a value-added business model where pricing is often driven by proprietary metallurgical formulations and rigorous certification requirements for aerospace and medical grade components.
Investors looking for deeper insights into these industry cycles may find ValueRay to be a useful tool for further research. The company’s global footprint spans North America, Europe, and the Asia Pacific, positioning it as a key supplier in the advanced materials supply chain.
Headlines to watch out for
- Aerospace and defense demand drives specialty alloy sales
- Raw material price volatility impacts production costs
- Energy sector capital expenditure influences order volume
- Medical device manufacturing growth boosts high-performance material demand
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income: 434.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.09 > 0.02 and ΔFCF/TA 1.35 > 1.0 |
| NWC/Revenue: 45.62% < 20% (prev 41.98%; Δ 3.64% < -1%) |
| CFO/TA 0.14 > 3% & CFO 503.7m > Net Income 434.9m |
| Net Debt (466.8m) to EBITDA (732.4m): 0.64 < 3 |
| Current Ratio: 4.25 > 1.5 & < 3 |
| Outstanding Shares: last quarter (50.3m) vs 12m ago -0.79% < -2% |
| Gross Margin: 28.85% > 18% (prev 0.24%; Δ 2.86k% > 0.5%) |
| Asset Turnover: 86.20% > 50% (prev 86.51%; Δ -0.31% > 0%) |
| Interest Coverage Ratio: 11.05 > 6 (EBITDA TTM 732.4m / Interest Expense TTM 53.3m) |
Altman Z'' 6.94
| A: 0.38 (Total Current Assets 1.76b - Total Current Liabilities 412.8m) / Total Assets 3.50b |
| B: 0.55 (Retained Earnings 1.92b / Total Assets 3.50b) |
| C: 0.17 (EBIT TTM 589.2m / Avg Total Assets 3.42b) |
| D: 1.41 (Book Value of Equity 2.14b / Total Liabilities 1.52b) |
| Altman-Z'' Score: 6.94 = AAA |
Beneish M -3.19
| DSRI: 1.04 (Receivables 603.5m/565.4m, Revenue 2.94b/2.88b) |
| GMI: 0.83 (GM 28.85% / 24.02%) |
| AQI: 0.93 (AQ_t 0.10 / AQ_t-1 0.11) |
| SGI: 1.02 (Revenue 2.94b / 2.88b) |
| TATA: -0.02 (NI 434.9m - CFO 503.7m) / TA 3.50b) |
| Beneish M-Score: -3.19 (Cap -4..+1) = AA |
What is the price of CRS shares?
As of March 15, 2026, the stock is trading at USD 408.14 with a total of 383,586 shares traded.
Over the past week, the price has changed by -6.67%, over one month by -4.88%, over three months by +11.70% and over the past year by +105.52%.
Over the past week, the price has changed by -6.67%, over one month by -4.88%, over three months by +11.70% and over the past year by +105.52%.
Is CRS a buy, sell or hold?
Carpenter Technology has received a consensus analysts rating of 4.29.
Therefore, it is recommended to buy CRS.
- StrongBuy: 4
- Buy: 1
- Hold: 2
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the CRS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 412.8 | 1.1% |
| Analysts Target Price | 412.8 | 1.1% |
CRS Fundamental Data Overview March 13, 2026
P/E Trailing = 46.7514
P/E Forward = 23.3645
P/S = 6.9059
P/B = 10.0866
P/EG = 1.5913
Revenue TTM = 2.94b USD
EBIT TTM = 589.2m USD
EBITDA TTM = 732.4m USD
Long Term Debt = 690.1m USD (from longTermDebt, last quarter)
Short Term Debt = 8.60m USD (from shortTermDebt, last quarter)
Debt = 698.7m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 466.8m USD (from netDebt column, last quarter)
Enterprise Value = 20.80b USD (20.33b + Debt 698.7m - CCE 231.9m)
Interest Coverage Ratio = 11.05 (Ebit TTM 589.2m / Interest Expense TTM 53.3m)
EV/FCF = 65.68x (Enterprise Value 20.80b / FCF TTM 316.7m)
FCF Yield = 1.52% (FCF TTM 316.7m / Enterprise Value 20.80b)
FCF Margin = 10.76% (FCF TTM 316.7m / Revenue TTM 2.94b)
Net Margin = 14.77% (Net Income TTM 434.9m / Revenue TTM 2.94b)
Gross Margin = 28.85% ((Revenue TTM 2.94b - Cost of Revenue TTM 2.09b) / Revenue TTM)
Gross Margin QoQ = 29.99% (prev 29.49%)
Tobins Q-Ratio = 5.94 (Enterprise Value 20.80b / Total Assets 3.50b)
Interest Expense / Debt = 1.46% (Interest Expense 10.2m / Debt 698.7m)
Taxrate = 19.0% (24.7m / 130.0m)
NOPAT = 477.3m (EBIT 589.2m * (1 - 19.00%))
Current Ratio = 4.25 (Total Current Assets 1.76b / Total Current Liabilities 412.8m)
Debt / Equity = 0.35 (Debt 698.7m / totalStockholderEquity, last quarter 1.99b)
Debt / EBITDA = 0.64 (Net Debt 466.8m / EBITDA 732.4m)
Debt / FCF = 1.47 (Net Debt 466.8m / FCF TTM 316.7m)
Total Stockholder Equity = 1.89b (last 4 quarters mean from totalStockholderEquity)
RoA = 12.73% (Net Income 434.9m / Total Assets 3.50b)
RoE = 22.99% (Net Income TTM 434.9m / Total Stockholder Equity 1.89b)
RoCE = 22.82% (EBIT 589.2m / Capital Employed (Equity 1.89b + L.T.Debt 690.1m))
RoIC = 18.46% (NOPAT 477.3m / Invested Capital 2.59b)
WACC = 11.34% (E(20.33b)/V(21.03b) * Re(11.69%) + D(698.7m)/V(21.03b) * Rd(1.46%) * (1-Tc(0.19)))
Discount Rate = 11.69% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.10%
[DCF] Terminal Value 71.19% ; FCFF base≈292.3m ; Y1≈360.5m ; Y5≈614.0m
[DCF] Fair Price = 114.0 (EV 6.14b - Net Debt 466.8m = Equity 5.68b / Shares 49.8m; r=11.34% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 97.03 | EPS CAGR: 137.0% | SUE: 1.03 | # QB: 4
Revenue Correlation: 77.67 | Revenue CAGR: 11.20% | SUE: -0.38 | # QB: 0
EPS current Year (2026-06-30): EPS=10.32 | Chg7d=+0.183 | Chg30d=+0.180 | Revisions Net=+4 | Growth EPS=+38.0% | Growth Revenue=+8.5%
EPS next Year (2027-06-30): EPS=12.05 | Chg7d=+0.715 | Chg30d=+0.717 | Revisions Net=+2 | Growth EPS=+16.8% | Growth Revenue=+10.8%
[Analyst] Revisions Ratio: +1.00 (4 Up / 0 Down within 30d for Current Year)
[Growth] Implied Growth Rate = 9.6% (Discount Rate 11.7% - Earnings Yield 2.1%)
[Growth] Growth Spread = +1.3% (Analyst 10.8% - Implied 9.6%)
P/E Forward = 23.3645
P/S = 6.9059
P/B = 10.0866
P/EG = 1.5913
Revenue TTM = 2.94b USD
EBIT TTM = 589.2m USD
EBITDA TTM = 732.4m USD
Long Term Debt = 690.1m USD (from longTermDebt, last quarter)
Short Term Debt = 8.60m USD (from shortTermDebt, last quarter)
Debt = 698.7m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 466.8m USD (from netDebt column, last quarter)
Enterprise Value = 20.80b USD (20.33b + Debt 698.7m - CCE 231.9m)
Interest Coverage Ratio = 11.05 (Ebit TTM 589.2m / Interest Expense TTM 53.3m)
EV/FCF = 65.68x (Enterprise Value 20.80b / FCF TTM 316.7m)
FCF Yield = 1.52% (FCF TTM 316.7m / Enterprise Value 20.80b)
FCF Margin = 10.76% (FCF TTM 316.7m / Revenue TTM 2.94b)
Net Margin = 14.77% (Net Income TTM 434.9m / Revenue TTM 2.94b)
Gross Margin = 28.85% ((Revenue TTM 2.94b - Cost of Revenue TTM 2.09b) / Revenue TTM)
Gross Margin QoQ = 29.99% (prev 29.49%)
Tobins Q-Ratio = 5.94 (Enterprise Value 20.80b / Total Assets 3.50b)
Interest Expense / Debt = 1.46% (Interest Expense 10.2m / Debt 698.7m)
Taxrate = 19.0% (24.7m / 130.0m)
NOPAT = 477.3m (EBIT 589.2m * (1 - 19.00%))
Current Ratio = 4.25 (Total Current Assets 1.76b / Total Current Liabilities 412.8m)
Debt / Equity = 0.35 (Debt 698.7m / totalStockholderEquity, last quarter 1.99b)
Debt / EBITDA = 0.64 (Net Debt 466.8m / EBITDA 732.4m)
Debt / FCF = 1.47 (Net Debt 466.8m / FCF TTM 316.7m)
Total Stockholder Equity = 1.89b (last 4 quarters mean from totalStockholderEquity)
RoA = 12.73% (Net Income 434.9m / Total Assets 3.50b)
RoE = 22.99% (Net Income TTM 434.9m / Total Stockholder Equity 1.89b)
RoCE = 22.82% (EBIT 589.2m / Capital Employed (Equity 1.89b + L.T.Debt 690.1m))
RoIC = 18.46% (NOPAT 477.3m / Invested Capital 2.59b)
WACC = 11.34% (E(20.33b)/V(21.03b) * Re(11.69%) + D(698.7m)/V(21.03b) * Rd(1.46%) * (1-Tc(0.19)))
Discount Rate = 11.69% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.10%
[DCF] Terminal Value 71.19% ; FCFF base≈292.3m ; Y1≈360.5m ; Y5≈614.0m
[DCF] Fair Price = 114.0 (EV 6.14b - Net Debt 466.8m = Equity 5.68b / Shares 49.8m; r=11.34% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 97.03 | EPS CAGR: 137.0% | SUE: 1.03 | # QB: 4
Revenue Correlation: 77.67 | Revenue CAGR: 11.20% | SUE: -0.38 | # QB: 0
EPS current Year (2026-06-30): EPS=10.32 | Chg7d=+0.183 | Chg30d=+0.180 | Revisions Net=+4 | Growth EPS=+38.0% | Growth Revenue=+8.5%
EPS next Year (2027-06-30): EPS=12.05 | Chg7d=+0.715 | Chg30d=+0.717 | Revisions Net=+2 | Growth EPS=+16.8% | Growth Revenue=+10.8%
[Analyst] Revisions Ratio: +1.00 (4 Up / 0 Down within 30d for Current Year)
[Growth] Implied Growth Rate = 9.6% (Discount Rate 11.7% - Earnings Yield 2.1%)
[Growth] Growth Spread = +1.3% (Analyst 10.8% - Implied 9.6%)